Log in to search using one of your social media accounts:

 

Zydus Cadila gets USFDA nod for two drugs
The group has also received the tentative approval for Solifenacin Succinate tablets in strengths of 5 mg and 10 mg, Zydus Cadila said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 15, 2017 Category: Pharmaceuticals Source Type: news

Glenmark Pharma's overactive bladder drug gets USFDA nod
According to IMS Health April 2017 sales data, the market for Vesicare tablets, 5 mg and 10 mg, saw annual sales of approximately USD 1.1 billion. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2017 Category: Pharmaceuticals Source Type: news

SMC backs drug for male urinary symptoms in Scotland
The Scottish Medicines Consortium has approved solifenacin 6mg/tamsulosin 0.4mg (Vesomni) for use in NHS Scotland. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - March 24, 2014 Category: Nursing Source Type: news

FDA OK’s First OTC Remedy For Overactive Bladder
WebMD Medical News By Kathleen Doheny Reviewed by Laura J. Martin, MD Jan. 25, 2013 — The FDA has approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women 18 and older. The condition affects more than 20 million American women, according to Merck, the drug’s manufacturer. It will still only be available in prescription form for men. Oxytrol helps relax the overactive bladder muscle that leads to symptoms such as the sudden need to urinate and leaking of urine. Oxytrol for Women is in the form of a patch, applied to the skin every four days, Merck says. It is expected to ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 30, 2013 Category: Consumer Health News Authors: mreal197 Tags: WebMD News Source Type: news